Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
Fluocinolone-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
Fluocinolone acetonide topical preparation (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Fluocinolone acetonide (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
Product containing fluocinolone in topical dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
Cutaneous ointment |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator value |
250 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has precise active ingredient |
Fluocinolone acetonide (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has basis of strength substance (attribute) |
Fluocinolone acetonide (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator unit |
mcg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
Product containing only fluocinolone in cutaneous dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|